RFX1 binds and regulates the enhancers of a number of viruses and cellular genes. RFX1 belongs to the evolutionarily conserved RFX protein family that shares a DNAbinding domain and a conserved C-terminal region. In RFX1 this conserved region mediates dimerization, and is followed by a unique C-terminal tail, containing a highly acidic stretch. In HL-60 cells nuclear translocation of RFX1 is regulated by protein kinase C with unknown mechanisms. By confocal fluorescence microscopy, we have identified a nonclassical nuclear localization signal (NLS) at the extreme C-terminus. The adjacent`acidic region', which showed no independent NLS activity, potentiated the function of the NLS. Subcellular fractionation showed that the tight association of RFX1 with the nucleus is mediated by its DNA-binding domain and enhanced by the dimerization domain. In contrast, the acidic region inhibited nuclear association, by down-regulating the DNA-binding activity of RFX1. These data suggest an autoinhibitory interaction, which may regulate the function of RFX1 at the level of DNA binding. The C-terminal tail thus constitutes a composite localization domain, which on the one hand mediates nuclear import of RFX1, and on the other hand inhibits its association with the nucleus and binding to DNA. The participation of the acidic region in both activities suggests a mechanism by which the nuclear import and DNA-binding activity of RFX1 may be coordinately regulated by phosphorylation by kinases such as PKC.
The RFX family of DNA-binding proteins is highly conserved in evolution and includes members from yeast, Caenorhabditis elegans, mice, and humans, which function in various biological systems [1, 2] . RFX1 has been implicated in transcriptional regulation of various viral and cellular genes. Its EP (EF-C) binding site in the enhancers of hepatitis B virus (HBV), polyomavirus, equine infectious anemia virus LTR [3, 4] , cytomegalovirus and Epstein-Barr virus [5] , as well as binding sites in the promoters of MHC class II (X box) [6, 7] , ribosomal protein rpL30 [8] , and interleukin-5 receptor a5 [9] genes, are positively acting regulatory elements in their natural context. In contrast, multimers of the EP site have no stimulatory effect on their own, and can silence the transcriptional activity of different enhancers [3, 10] . The EP site was also shown to participate in transcriptional repression induced by p53 [11] . RFX1 binding sites in the intron of c-myc gene [10, 12] , proliferating cell nuclear antigen promoter [13] and the collagen a2(I) gene [14] were implicated in transcriptional down-regulation. By functional dissection, we demonstrated that RFX1 possesses transcriptional activation and repression domains [15] these domains function independently, and can mutually neutralize each other's effect. Although multiple activities have been assigned for RFX1, in the absence of RFX1-deficient animals or cells, the exact physiological role of this protein has yet to be determined.
The 140-kDa RFX1 protein is composed of several distinct regions. Functional domains include the centrally located DNA-binding domain (DBD) and the C-terminal B-C-D region [16] , which mediates dimerization and transcriptional repression. The N-terminal part includes several glutamine-rich regions, one of which overlaps the activation domain [15] , and a proline-rich region, which mediates the interaction with c-Abl17. While the opposing activities of the activation and repression domains may modulate the RFX1 function at the transcriptional level, the DNA-binding activity of this protein is not known to be regulated. The conserved B-C-D region of RFX1 is followed by a C-terminal tail, which shows no obvious homology to the C-termini of the other RFX proteins. Structurally, this unique tail is composed of two parts: thè acidic region', containing a stretch of acidic residues, followed by the extreme C-terminal region, with no distinct sequence feature. Using confocal fluorescence microscopy, combined with subcellular fractionation and gel shift analysis, we now show that the C-terminal tail affects the nuclear localization and DNA-binding properties of RFX1. The extreme C-terminal region contains the major nuclear localization signal (NLS) of RFX1, whose function is potentiated by the adjacent acidic region. In contrast, the acidic region seems to inhibit the association of RFX1 with the nucleus and its binding to DNA, both mediated by the DBD and the dimerization domain. The C-terminal tail thus constitutes a composite localization domain, which targets RFX1 to the nucleus but also down-regulates its DNA-binding activity. The acidic region plays a role in both functions, raising the possibility that the nuclear import rate of RFX1 and its DNA-binding activity may be coordinately regulated.
M A T E R I A L S A N D M E T H O D S

Plasmid constructions
Plasmids expressing the wild-type and mutant RFX1 are based on pSG5RFX1, which expresses the RFX1 cDNA under the control of the SV2 promoter [4] . HARFX1 and the different RFX1 mutants were tagged at their N-termini with the haemagglutinin (HA) epitope, and their structures have mostly been described previously [15, 17] . All plasmids expressing green fluorescent protein (GFP) derivatives are based on pEGFP-C1 (Clontech), which encodes a red-shifted variant of wild-type GFP (EGFP).
Cell culture, transfections, and fluorescence microscopy Cells were cultured and transfected as described previously [15] . Indirect immunofluorescence analysis was performed essentially as described previously [18] . Fixed cells were double-stained for 1 h at room temperature with the mouse mAb anti-HA (Babco) diluted 1 : 800 or rabbit anti-RFX1 serum, produced in our laboratory, diluted 1 : 100, together with the M-20 goat polyclonal anti-(lamin B) Ig (Santa Cruz Biotechnology) diluted 1 : 600. Anti-HA and anti-RFX1 RFX1 was detected with a fluorescein isothiocyanate-labeled secondary antibody. Lamin B was detected with a tetramethylrhodamine isothiocyanate-labeled secondary antibody, to mark the nuclei. (B) Structure and subcellular localization of HARFX1 derivatives. Shown schematically are the structures of the wild-type HARFX1 and its mutant derivatives, harbouring the indicted amino acid deletions. In m780±2, residues 780±782 have been substituted from RVD to ASG. The DNA-binding domain (DBD) and conserved B-C-D region, which constitutes the dimerization domain, are indicated. The sequence of the C-terminal tail (residues 913±979), including the acidic region (Ac), is shown at the top. The subcellular localization of the different HARFX1 derivatives was determined by staining of transiently transfected COS-1 cells with anti-HA Ig, following their fixation, and visualization by fluorescence confocal microscopy, as shown in Fig. 3 . For each protein, its localization in the majority of transfected cells is marked as follows: N, exclusively nuclear staining; N q C, strong nuclear staining and substantially weaker cytoplasmic staining; N . C, strong nuclear staining and moderate cytoplasmic staining; C N, ubiquitous staining throughout the cell; C q N, strong cytoplasmic staining and substantially weaker nuclear staining; C, exclusively cytoplasmic staining.
were detected with fluorescein isothiocyanate-conjugated donkey anti-mouse or donkey anti-rabbit Ig (Jackson Laboratories), respectively, diluted 1 : 90. Anti-(lamin B) Ig was detected with a tetramethylrhodamine isothiocyanate-conjugated donkey anti-(goat Ig) Ig diluted 1 : 90, to mark the nuclei. The cells were mounted in 9 : 1 glycerol/ NaCl/P i with 0.1% p-phenylenediamine, and visualized in a Bio-Rad MRC-1024 confocal system, utilizing an Argon/ Krypton mixed gas lazer, and mounted on a Zeiss Axiovert microscope.
For green fluorescence, cells were grown on coverslips and transfected by calcium phosphate precipitation, using 1.25 mg DNA. GFP fluorescence was visualized in live cells by confocal microscopy.
Subcellular fractionation, Western blot and gel-shift analysis
Subcellular fractionation into nuclear and cytoplasmic extracts was performed using hypotonic swelling buffer, as described previously [15] , except that nuclei were extracted in buffer A (20 mm Hepes/KOH, pH 7.9, 250 mm NaCl, 1% Triton X-100, 5 mm EDTA, 1 mm dithiothreitol, and a cocktail of protease inhibitors), and the swelling buffer contained protease inhibitors. Equivalent cell numbers of the nuclear and cytoplasmic fractions were resolved by SDS/PAGE using 7.5% (Fig. 3) or 10% (Fig. 4) polyacrylamide gels, and electroblotted onto nitrocellulose membranes. The membranes were reacted with rabbit anti-RFX1 serum, produced in our laboratory, followed by protein A conjugated with horseradish peroxidase, or with the anti-HA monoclonal antibody (Babco), followed by goat anti-(mouse Ig) Ig conjugated with horseradish peroxidase. The immune complexes were detected using the SuperSignal chemiluminescent substrate (Pierce).
Gel shift analysis of whole-cell extracts was performed as previously described [19] .
R E S U L T S
Nuclear localization of RFX1 is determined by its extreme C-terminus
To determine the subcellular distribution of the endogenous RFX1, COS-1 cells were fixed and stained with the anti-RFX1 Ig. Immunofluorescence confocal microscopy showed RFX1 to be found exclusively in the nucleus, with the exclusion of nucleoli (Fig. 1A) . The localization of RFX1 was further examined by overexpressing this protein, tagged at its N-terminus with the HA epitope (HARFX1), in COS-1 cells, and staining the cells with anti-HA. The overexpressed RFX1 was found exclusively in the nucleus, with the exclusion of the nucleoli, similar to the endogenous protein. In order to define the sequence that directs RFX1 to the nucleus, different deleted derivatives of HARFX1 were examined. Deletion of amino-acid residues 1±351 or 1±415 at the N-terminus of RFX1 did not alter its nuclear localization (Fig. 1B) . A similar nuclear distribution was observed upon deletion of residues 790±867, 766±812, 791±913, 603±913, or 528±913 within the C-terminal half of RFX1 or residues 351±527, encompassing the DBD. Deletion of the N-terminus (residues 1±415), the DBD (residues 351±527), and the B-C-D region (residues 528±913) are not essential for directing RFX1 to the nucleus. In contrast, truncation of RFX1 at residue 914 dramatically altered its subcellular localization (Fig. 1A) . The combined deletions of the DBD (residues 351±527) and the C-terminal tail (residues 915±979) resulted in exclusively cytoplasmic localization. A mutant deleted of residues 77±588 and 915±979 was distributed in the nucleus and cytoplasm at similar levels; the relatively small size of this mutant is likely to account for its ubiquitous staining. These results indicate that the C-terminal 65 residues of RFX1 are essential for its nuclear localization and are likely to contain an NLS. However, the C602 mutant, truncated at residue 602, was detected preferentially in the nucleus, with a relatively weak cytoplasmic staining (Fig. 1A) . The C-terminal tail of RFX1 includes a highly acidic stretch of 17 residues (920±936), 14 of which are aspartic acid or glutamic acid. To further localize the C-terminal NLS with respect to this sequence, residues 914±936 were deleted, to generate DAc. This mutant showed exclusively nuclear staining, indicating that the acidic region is not required for directing RFX1 to the nucleus, thus localizing the NLS function to residues 937±979
The extreme C-terminus and the DBD of RFX1 can each direct GFP to the nucleus Because the deletion analysis attributed a nuclear localization function to the C-terminal tail of RFX1, we examined whether this sequence can direct a heterologous protein to the nucleus, by fusing it to the C-terminal end of an HA-tagged green fluorescent protein (GFP), to generate GFP-913. The GFP derivatives were expressed in COS-1 and 293 cells, and GFP fluorescence was visualized in live cells (Fig. 2) . The parental HA±GFP could freely enter the nucleus due to its small size, and thus showed ubiquitous staining in both the cytoplasm and the nucleus ( Fig. 2A) , as previously reported [20] . In contrast, GFP-913 accumulated predominantly in the nucleus, with only very weak cytoplasmic staining (Fig. 2B) . Thus, residues 913±979 are required and sufficient for nuclear targeting, strongly suggesting that this region contains an NLS.
To further localize the C-terminal NLS, the GFP fusions GFP-Ac and GFP-937 were generated, containing RFX1 residues 913±941 (including the acidic stretch) and 937±979, respectively. GFP-Ac showed ubiquitous staining throughout the cell, similar to the parental HA±GFP, indicating that residues 913±941 do not have independent NLS activity (Fig. 2C) . In contrast, GFP-937 accumulated mainly in the nucleus (Fig. 2D) . Altogether, our analyses localize an independent NLS function to residues 937±979. The acidic region of residues 913±941 does not show independent NLS activity. As GFP-913 was localized to the nucleus more efficiently than GFP-937, the acidic region appears to potentiating the NLS function of residues 937±979.
The predominantly nuclear localization of the C602 mutant ( Fig. 1) suggested that a second, weaker NLS is found within residues 1±602 of RFX1. As the sequence that mostly resembles a classical basic NLS seemed to be the RTRR sequence within the DBD, we fused residues 434±536, which include the DBD, to GFP, generating GFP-DB. This fusion protein was detected mainly in the nucleus, with weaker cytoplasmic staining (Fig. 2E) . Thus, residues 434±536 can direct GFP to the nucleus, albeit less efficiently than the C-terminal tail.
Three additional GFP fusions were generated, GFP-DB913, GFP-DBAc, and GFP-DB937, which contain the RFX1 DBD (residues 434±536) together with residues 913±979, 913±941, and 937±979, respectively. GFP-DB913 and GFP-DB937 were detected predominantly in the nucleus, as expected (Fig. 2F,H) . Surprisingly, GFP-DBAc was ubiquitously distributed in both the cytoplasm and the nucleus, similar to HA±GFP (Fig. 2G) . This finding suggests that the acidic region can counteract the ability of the RFX1 DBD to direct GFP to the nucleus. A possible mechanism for this counteracting effect will be discussed below. 
Subcellular fractionation of RFX1 derivatives
The subcellular distribution of RFX1 was further examined by fractionating cells into nuclear and cytoplasmic extracts. The endogenous and overexpressed RFX1 appeared predominantly in the nuclear fraction (Fig. 3) . Several RFX1 derivatives, shown by immunofluorescence microscopy to be predominantly nuclear (Fig. 1) , were examined by fractionation, in comparison with the wild-type RFX1 (Fig. 3B) . Mutants with a deletion of the DBD (residues 351±527) or residues 77±588 were found almost exclusively in the cytoplasmic fraction (Fig. 3B, lanes 11±14) . Similarly, several mutants bearing deletions in the B-C-D region (DBCD, D791-913, D790-867, and D766-812) appeared exclusively or predominantly in the cytoplasmic fraction ( lanes 7±10, 21 224, 27±28, 31±32, and 35±36) . Collectively, our findings show that mutations within the DBD or the dimerization domain (B-C-D region) cause RFX1 derivatives to accumulate mainly in the cytoplasmic fraction, although these mutants show exclusively nuclear distribution by microscopy. It therefore appears that, while the wild-type RFX1 is tightly associated with the nucleus and is thus largely retained in the nuclear fraction, the mutant proteins are loosely associated, and therefore partition into the cytoplasm when the cell is disrupted. Thus, the cytoplasmic fractionation of these mutants indicates their impaired association with the nucleus compared to the wild-type RFX1. A similar phenomenon was previously observed with the estrogen receptor, which exists in two nuclear forms, a tightly associated form, present in the nuclear fraction, and a loosely associated form, which partitions in the cytoplasmic fraction [21±23] .
Because the B-C-D region constitutes the dimerization domain, it was possible that the impaired nuclear association of proteins deleted in this region resulted from their inability to dimerize. To address this possibility, we examined the m780±2 mutant, in which residues 780±782 of region D had been substituted, resulting in a partially impaired dimerization capacity (data not shown). In experiments where the wild-type RFX1 appeared mainly in the nuclear fraction, m780±2 showed similar levels in the nuclear and cytoplasmic fractions (Fig. 3B , compare lanes 5 and 6 with lanes 1 and 2). Thus, the nuclear association of the RFX1 derivatives correlated with their dimerization derivatives. Whole-cell extracts were incubated with the EP probe on ice. After 40 min, an excess of unlabeled competitor EP DNA was added, and incubation proceeded at room temperature. Aliquots were loaded on a mobility shift gel for 0±60 min following competitor addition, as indicated. The wild-type RFX1 forms the two DNA±protein complexes a and a*, marked by a thin arrow and an asterisk, respectively; the mutants form only complex a. (E) The data from (D) were quantified and relative binding was determined as in (B).
capacity. Altogether, this analysis shows that mutations within the DBD or the dimerization domain dramatically decrease the retention of RFX1 in the nuclear fraction, suggesting that the tight association of RFX1 with the nucleus is mediated by its DNA-binding and dimerization functions.
Interestingly, while the DBCD mutant was found exclusively in the cytoplasmic fraction, the C602 mutant was also found in the nuclear fraction (Fig. 3B) . As the two mutants were shown by microscopy to accumulate mostly in the nucleus, they appear to differ in their nuclear retention. In contrast to the C602 mutant, DBCD contains the acidic region, suggesting that the inhibition of nuclear association is mediated by this region.
Inhibition of DNA-binding by the acidic region of RFX1
RFX1 DBD forms direct contacts with the DNA, and alone is sufficient for DNA binding, while the dimerization domain stabilizes this interaction [16, 19] . Therefore, it was possible that the acidic region inhibits nuclear association by counteracting the DNA-binding activity of RFX1. To determine the intrinsic DNA-binding capacity of different RFX1 derivatives, serial dilutions of extracts from transfected cells were performed, and all samples were examined in parallel for DNA-binding activity and protein level, by gel shift and Western analyses, respectively (Fig. 4A±C) . The effect of the C-terminal tail on DNAbinding by comparing the wild-type RFX1 with the C914 and DAc mutants, which lack residues 915±979 or 914±936, respectively, was examined. These mutants show improved DNA affinity versus the wild-type as determined by quantifying relative binding efficiency at different protein concentrations (Fig. 4A,B) . We further examined the DNA-binding capacity of the two dimerization-deficient mutants DBCD and C602, the latter lacks the C-terminal tail. A pronounced difference between the two proteins was evident and the DNA-binding activity of C602 is markedly higher than that of DBCD, suggesting that the C-terminal tail of RFX1 reduces DNA interaction.
The inhibitory effect of the C-terminal tail might be exerted by altering either the association with or the dissociation from DNA. To address these possibilities, an off-rate experiment was performed (Fig. 4D,E) . As previously reported [19] , the dimerization-deficient DBCD dissociated from DNA more rapidly than the overexpressed wild-type RFX1. Interestingly, C602 lacking the C-terminal tail showed an even faster dissociation rate. Therefore, the enhanced DNA-binding capacity of C602 compared to DBCD appears not to result from increased DNA-binding stability. These data suggest that the C-terminal tail of RFX1 may inhibit DNA-binding by affecting the rate of association with DNA; and RFX1 dimerization domain is required to stabilize the established complex.
D I S C U S S I O N
The C-terminal parts of most RFX proteins contain the conserved B-C-D region. In RFX1 this conserved region is followed by a C-terminal tail, showing no obvious homology to the C-termini of the other RFX proteins. Structurally, this unique tail is composed of two parts: the acidic region (residues 913±936), containing a stretch of acidic residues, followed by the extreme C-terminal region (residues 937±979; Fig. 1 ). The present study attributes distinct functions to the two parts, suggesting that the C-terminal tail of RFX1 functions as a composite localization domain, which targets RFX1 to the nucleus, yet also down-regulates nuclear association and DNA-binding. The acidic region, which participates in these different activities, may thus play an important role in regulation of function of RFX1 at the levels of nuclear import and DNA-binding.
The RFX1 C-terminal NLS does not show clear sequence similarity to classical NLSs [25] , but includes three basic amino acids, within the sequence KLARTDAR. Further analysis is needed to determine whether this sequence exerts the NLS function. However, the C-terminal tail of RFX1 bears some resemblance to the composite nuclear targeting motif of the simian virus 40 large T-antigen, which includes a typical basic NLS preceded by the protein kinase CK2 phosphorylation site SSDDE. While the T-antigen NLS is sufficient for nuclear targeting, phosphorylation at the CK2 site increases the rate of nuclear import [26, 27] . Substitution of a serine residue with aspartic acid can simulate the effect of phosphorylation in accelerating nuclear import, implying that it is the negative charge at the CK2 site that is important in this process. A similar composite motif is present in nucleoplasmin, where a basic NLS is followed by the EDESSEED CK2 phosphorylation site [28] . Putative composite targeting motifs, including a basic NLS and an acidic CK2 site, are found in a variety of other proteins, and may similarly serve for mediating regulated nuclear import [26, 29] . In RFX1, the C-terminal NLS is preceded by the acidic region, which includes the putative CK2 phosphorylation site SEDE (Fig. 1) . Like the acidic CK2 phosphorylation sites of the T-antigen and nucleoplasmin, the acidic region of RFX1 appears to enhance nuclear import mediated by the adjacent NLS. Thus, the C-terminal tail of RFX1 may function similarly to the composite nuclear targeting motifs, in which the NLS and the acidic CK2 site cooperate in mediating rapid nuclear import. The acidic stretch of RFX1, however, exceeds the number of acidic residues at the reported CK2 sites. As the negative charge at this site appears to be important for nuclear import acceleration, the larger acidic region of RFX1 may be sufficient for mediating this function even in the absence of phosphorylation.
The extreme C-terminal 43 residues, of RFX1 are both necessary and sufficient for nuclear targeting, however, our results also suggest the existence of an additional, weaker NLS, sufficient for directing the dimerization-deficient C602 mutant, but not the wild-type RFX1, to the nucleus. This additional NLS could serve for increasing the rate of nuclear import, which becomes important under specific conditions [29] . Fusion of the DBD (residues 434±536) to GFP (GFP-DB) indicated that this region can direct GFP to the nucleus, albeit less efficiently than the C-terminal tail (Fig. 2) . The DBD includes the sequence RTRR, which bears some resemblance to a classical basic NLS, and can possibly function as the second NLS of RFX1. Alternatively, as the relatively small GFP fusion proteins can freely diffuse across the nuclear membrane to association with the DNA.
Inhibition of nuclear association and DNA-binding by the acidic region.
In addition to its potentiating effect on the C-terminal NLS, the acidic region exerts an inhibitory effect on the association with the nucleus. In subcellular fractionation experiments, a significant portion of the overexpressed wild-type RFX1 was found in the nuclear fraction, while several nuclear RFX1 mutants (as determined by microscopy) were found predominantly in the cytoplasmic fraction, indicating of impaired nuclear association. The tight association of RFX1 with the nucleus depends on its DBD; deletion of this region from the wild-type RFX1 abolished nuclear association, and fusion of the DBD conferred nuclear association properties on GFP (in GFP-DB). Nuclear association was also affected by the dimerization domain (B-C-D region), as RFX1 mutants bearing deletions within this domain were found predominantly in the cytoplasmic fraction, and nuclear association correlated with dimerization capacity. Interestingly, deletion of the C-terminal tail from the dimerization-deficient DBCD mutant (construct C602) restored tight nuclear association, suggesting that the C-terminal tail inhibits the association of RFX1 with the nucleus. Furthermore, deletion of only the acidic region from the wild-type RFX1 (construct DAc) increased its retention in the nuclear fraction (Fig. 3 ). These observations, and dissection of the C-terminal tail in the context of GFP-DB, have localized the inhibitory function to the acidic region. Thus, the tight association of RFX1 with the nucleus is mediated by the DBD and enhanced by the dimerization domain, whereas the acidic region inhibits nuclear association.
Although the DBD of RFX1 alone can independently bind DNA, the DNA-binding capacity of RFX1 is determined by cooperation between the DBD and the dimerization domain, the former directly contacting the DNA, and the latter stabilizing DNA-binding by linking between the dimer subunits. The effects of these domains on nuclear association are likely to result from their cooperation in mediating stable DNA-binding. The acidic region could therefore exert its inhibitory effect on nuclear association by down-regulating the DNA-binding affinity of RFX1, as suggested by gel shift analysis (Fig. 4) . Of the two dimerization-deficient mutants DBCD and C602, which differ by the presence of the C-terminal tail in DBCD, C602 showed a markedly increased nuclear association and DNA-binding capacity. Taken together, our results suggest that the acidic region inhibits the association of RFX1 with the nucleus by down-regulating its DNA-binding activity.
As the DBD of RFX1 contains a high percentage of basic residues, the negatively charged acidic region may inhibit DNA-binding by interacting with a positively charged sequence within the DBD, preventing it from binding its DNA site (Fig. 5 ). Our findings thus propose an autoinhibitory mechanism, by which the function of RFX1 may be regulated at the level of DNA-binding. Such an autoinhibitory interaction with the DBD is more likely to reduce the rate of association with DNA, rather than the stability of DNA-binding. Off-rate experiments suggest that the higher DNA-binding activity of C602 may be due to a faster association rate, rather than enhanced DNA-binding stability (Fig. 4) , consistent with the proposed autoinhibition mechanism. How the binding of RFX1 to DNA is regulated under physiological conditions is presently unclear. Crt1, the Saccharomyces cerevisiae homologue of RFX1, is a transcriptional repressor that dissociates from its DNA-binding sites upon phosphorylation [30] . Phosphorylation may also regulate the DNA-binding activity of RFX1 [31] . This may provide the mechanism behind the recent report that activation of protein kinase C induces nuclear translocation of RFX1 [32] . In addition, RFX1 can interact with the c-Abl tyrosine kinase and potentiate its kinase activity [17] . These data suggest a possible mechanism for relief of the autoinhibition exerted by the acidic region, by which phosphorylation of RFX1 may lead Fig. 5 . A model describing a possible autoinhibitory mechanism, by which the acidic region may counteract the DNA-binding activity of RFX1. RFX1 is found in an equilibrium between inhibited and uninhibited states. In the inhibited state, the negatively charged acidic region interacts with the positively charged DBD and thus prevents DNA-binding. In the uninhibited state, the interaction between the acidic region and the DBD is disrupted, allowing the DBD to bind its DNA site. The scheme shows an RFX1 homodimer in its inhibited, unbound state (left) and its uninhibited, DNA-bound state (right). The inhibition could potentially occur either in cis, with the acidic region interacting with the DBD of the same RFX1 molecule (upper dimer), or in trans, with the acidic region of one molecule interacting with the DBD of the other (lower dimer). The N-terminal end (N), DBD, dimerization domain (EDD), and acidic region (Ac) of RFX1 are indicated.
to disruption of the interaction between the acidic region and the DBD, and thus allow rapid DNA-binding.
The acidic region also seems to affect the distribution of RFX1 within the nucleus. By microscopy analysis, the DAc RFX1 mutant showed an altered intranuclear staining pattern, as compared to the wild-type RFX1, appearing to accumulate preferentially in distinct subnuclear foci (Fig. 1) . The effects of the acidic region on intranuclear distribution, nuclear association, and DNA-binding may also be concomitantly regulated. Relief of the autoinhibition would thus produce an RFX1 protein with increased DNA-binding capacity and tighter nuclear association, which localizes into distinct regions within the nucleus.
The acidic region ± a bifunctional motif
If the DBD indeed contains the second NLS of RFX1 (this remains to be confirmed), both its NLS and DNA-binding properties may be subject to inhibition by the acidic region. Thus, disruption of the autoinhibitory interaction would have a dual stimulatory effect on the function of RFX1, in exposing both the DBD and the additional NLS embedded within it, thereby increasing the DNA-binding capacity of RFX1 as well as its rate of nuclear import. Moreover, as the acidic region also acts in concert with the C-terminal NLS to mediate nuclear import, maximal potentiation of the function of RFX1 may involve both relief of the inhibitory effect exerted by the acidic region (on DNA-binding, and possibly nuclear import) and utilization of its stimulatory activity (on nuclear import mediated by the C-terminal NLS). It is thus possible that the composite structure of the C-terminal tail, in which a single motif is used for two different functions, allows the coordinated regulation of the nuclear import rate of RFX1 and its DNA-binding activity. By such a mechanism, an as yet unidentified signal could lead to disruption of the autoinhibitory interaction between the acidic region and the DBD, thus enhancing DNA-binding activity of RFX1. The acidic region would then be free to cooperate with the C-terminal NLS, leading to an accelerated nuclear import rate. The`activated' RFX1 molecule would thus be rapidly targeted first, into the nucleus, and then, to its specific DNA site, to regulate transcription.
An autoinhibitory mechanism involving electrostatic interactions between a basic DBD and an acidic region may be of broader use in regulation of DNA-binding proteins. Such a mechanism may apply not only to acidic stretches, but also to less densely charged acidic regions, such as activation domains. In the latter case, not only the function of the DBD, but also that of the activation domain, could be suppressed by the inhibitory interaction. The regulation of the function of RFX1 proposed by our data may therefore represent a general mechanism by which transcription factors can be kept in a state of reduced activity via an intramolecular interaction, until receiving specific signals.
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